MD Anderson, TOPPAN launch joint venture for invivoid cancer treatment tech - InnovationMap
The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have formed a joint venture to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.| InnovationMap
